JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Citizens M&A Outlook Finds Surging Enthusiasm Supported by Unexpected Factors
-
Unity Software (U) layoffs a 'painful but necessary reset'
-
Morgan Stanley Initiates Research Coverage on Mondee
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Expensify, National Instruments, and LivePerson and Encourages Investors to Contact the Firm
-
EXPENSIFY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Expensify To Contact Him Directly
-
Allogene Therapeutics (ALLO) shares plunge, company announces 22% workforce reduction
-
PolyPid Ltd. (PYPD) Announces $16.2M Private Placement at $4.81/sh
-
PolyPid Announces Private Placement for $16 Million in Gross Proceeds
-
Aviat Networks to Participate in Upcoming Investor Conferences
-
Third Harmonic Bio (THRD) Appoints Christopher Murphy as Chief Financial and Business Officer, Provides Business Update
-
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
-
JMP Securities Starts Inovio Pharmaceuticals (INO) at Market Outperform
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ChargePoint, Expensify, and National Instruments and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ChargePoint, Expensify, and National Instruments and Encourages Investors to Contact the Firm
-
EXPENSIFY SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Expensify To Contact Him Directly To Discus
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
JMP Securities bullish on Coinbase (COIN) - sees same attributes that were present in Amazon decades ago
-
JMP Securities Price Target on Coinbase (COIN) Nearly Doubled to $200
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
Nuveen Churchill Direct Lending Corp. Files Registration Statement for Initial Public Offering
-
EXPENSIFY ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Expensify To Contact Him Directly To D
-
Ocular Therapeutix™ Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Shopify (SHOP) cut at JMP Securities as shift to enterprise weighs on gross profit margin
-
JMP Securities Downgrades Shopify (SHOP) to Market Perform, 'Shift to Enterprise Weighs on Gross Profit Margin'
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
EXPENSIFY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Expensify To Contact Him Directly
-
Chewy (CHWY) investor day underwhelms, 'not thesis changing' says analyst
-
Ocular Therapeutix (OCUL) Prices 30.8M Share Offering at $3.25/sh
-
Ocular Therapeutix™ Announces Pricing of Public Offering of Common Stock
-
Zillow's (ZG) share price represents a 'compelling opportunity' - JMP Securities
-
JMP Securities Upgrades Zillow Group (ZG) to Market Outperform, 'Strong Foundation for Share Gains'
-
HCI Group Announces Closing of Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Expensify, Inc. and Encourages Investors to Contact the Firm
-
HCI Group Announces Pricing of Underwritten Public Offering of Common Stock
-
HCI Group (HCI) Announces Proposed Public Offering of Common Stock
-
HCI Group Announces Proposed Public Offering of Common Stock
-
AG Mortgage Investment Trust, Inc. Completes Acquisition of Western Asset Mortgage Capital Corporation
-
Syros Pharmaceuticals (SYRS) Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine
-
Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine
-
Box stock plummets 13% after earnings, guidance miss; Analysts remain constructive
-
JMP Securities Downgrades Ares Commercial (ACRE) to Market Perform
-
JMP Securities Starts Hamilton Insurance Group (HG) at Market Outperform
-
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit
-
Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit
-
Allogene Therapeutics Announces Participation in December Investor Conference
-
Immix Biopharma to Present at the 2023 JMP Securities Hematology and Oncology Summit
-
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
-
F&G Annuities & Life Prices Senior Unsecured Notes Offering
-
Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
-
Precigen to Participate in the JMP Securities Hematology and Oncology Summit

